Original Article

Comparison of Different Techniques in Breast Cancer Radiotherapy Planning
  • F. Gülşen Kara
  • Ayfer Haydaroğlu
  • Hakan Eren
  • Gül Kitapçıoğlu
Eur J Breast Health 2014; 10: 83-87 DOI: 10.5152/tjbh.2014.1772
Were We Able to Reduce Cardiac Doses in Breast Cancer Radiotherapy Over Time?
  • Pelin Altınok
  • Latif Korkmaz
  • Ayse Altınok
  • Nuran Beşe
Eur J Breast Health 2021; 17: 145-149 DOI: 10.4274/ejbh.galenos.2021.6148 PMID:33870114
Is Electrocardiogram Helpful in Predicting a Rise in Troponin I as a Marker of Anthracycline Cardiotoxicity?
  • Kader Muneer
  • Benny Jose
  • Gajendra Dubey
  • Ajayakumar T
  • Sajeev CG
  • Krishnan MN
Eur J Breast Health 2022; 18: 299-305 DOI: 10.4274/ejbh.galenos.2022.2021-9-8 PMID:36248753

Review

A NEPHROLOGIST’S VIEW TO RENAL SAFETY OF BISPHOSPHONATES
  • Sevgi Şahin
Eur J Breast Health 2007; 3: 120-124

Case Report

RECURRENT SUPRAVENTRICULAR TACHYCARDIA ASSOCIATED WITH LAPATINIB: A CASE REPORT OF A PROBABLE CARDIAC ADVERSE EFFECT
  • Özgür Tanrıverdi
  • Nezih Meydan
  • Sabri Barutca
Eur J Breast Health 2011; 7: 188-190